The saying “you cannot manage what you cannot measure” applies to all aspects of healthcare delivery, but it is especially true in value-based care. After all, payers, providers, and the patients they care for need to know what high-value care looks like at an individual level – and how it can be applied at the population level.
Delivery and technology infrastructure. All too often, data is captured in disparate systems, forcing administrative staff – or, worse, physicians and nurses – to
Read More
care pathways
Luna Unveils Value-Based Savings Orthopedic Program
What You Should Know:
- Luna, the leading in-home physical therapy (PT) platform, today announces the launch of a value-based savings program for orthopedic practices to reduce post-acute care costs by 55-70%.
- Top orthopedic groups are turning to Luna to reduce costs and deliver this innovative, in-person form of care, including Hoag (Orange County), Resurgens Orthopaedics (Atlanta), and dozens of others.
Using At-Home PT Services To Reduce the Cost of Orthopedic
Read More
Rimidi and Boston Medical Release Metrics from Postpartum Hypertension RPM Program
What You Should Know:
- Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, and Boston Medical Center, a private, not-for-profit academic medical center in New England, recently released metrics from an ongoing remote patient monitoring program for new moms at high-risk of postpartum hypertension.
- Of the 1,000 patients monitored, 98.7% submitted at least one blood pressure measurement,
Read More
FDA Awards 510(k) Clearances for ZEUS System/Zio Watch
What You Should Know:
- Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, prescription-based solution that will improve clinician workflows, care pathways and the patient experience.
- The ZEUS System is the AI algorithm and solution component of the Zio Watch – a clinical grade, long-term and noninvasive wearable that not only
Read More
Pfizer and Sidekick Health Launches Digital Therapeutics Solution for Eczema
What You Should Know:
- Sidekick Health today announces the launch of an integrated digital therapeutics solution for improving the outcomes of patients with Atopic Dermatitis (AD) in conjunction with Pfizer Inc., one of the world's premier innovative biopharmaceutical companies.
- Sidekick and Pfizer will be rolling out their integrated digital therapeutics offering, launching first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022.
Read More
Cerner Collaboration to Increase Access to Cancer Clinical Trials
What You Should Know:
- Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.
- Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection.
Importance of Early Cancer Detection
Early
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention
What You Should Know:
- CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14M Series B financing round.
- The Series B round was co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures with participation from McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), and HealthX Ventures.
Inequality in
Read More
Viz.ai Awarded 510(k) Clearance for AI-Powered Cerebral Aneurysm Detection Solution
What You Should Know:
- Viz.ai, a San Francisco-based provider of AI-powered intelligent care coordination for stroke, has received FDA 510(k) clearance for Viz ANEURYSM (formerly Viz ANX), the first and only AI-powered cerebral aneurysm detection solution designed to facilitate population screening and enhanced care management.
- The new algorithm uses AI to detect suspected cerebral aneurysms, enabling hospital systems
Read More
Bright.md Expands Solution to Automate Pre-Visit Workflows
What You Should Know:
- Bright.md today announced the launch of its expanded solution to automate pre-visit workflows to drive efficiencies in care delivery
- Bright.md new three offerings include Navigate, Interview, and Treat.
- Navigate: Healthcare systems can now engage their patients and coordinate care delivery through the platform's new offering, Navigate. This product captures the symptoms and chief complaints from patients to instantly route them to the optimal care pathways
Read More
